Skip to content

Effectiveness of Automatic High Flow Oxygen Concentration Control System

Satety and effectiveness of Automatic adjustment of oxygen concentration using targeted SpO2 feedback(TSF) system

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0008038
Enrollment
18
Registered
2022-12-23
Start date
2019-05-07
Completion date
Unknown
Last updated
2023-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : In the case of using the target SpO2feedback system (TSF) mode and maintaining general high-flow oxygen therapy, it is divided into two groups, and a total of four times, two times ea

Sponsors

Asan Medical Center
Lead Sponsor
Inje University Ilsan Paik Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients over 18 years of age admitted to ICU Patients who use high-flow oxygen therapy such as hypoxic respiratory failure or pulmonary edema after tracheostomy

Exclusion criteria

Exclusion criteria: 1) loss of consciousness to the extent that patients are challenging to use HFNC 2) If the subject's respiratory failure deteriorates and mechanical ventilation is required 3) If subjects' respiration worsen enough to have a respiratory rate of 35 times or more per minute, 4) Patients unable to use HFNC due to structural abnormalities in the nasal-facial system

Design outcomes

Primary

MeasureTime frame
To verify the effectiveness of the TSF mode, the ratio of time achieved in the normal high flow mode to the target saturation range (94-96%) is compared

Secondary

MeasureTime frame
Number of manual adjustments in TSF mode and normal high flow oxygen mode

Countries

Korea, Republic of

Contacts

Public ContactWoo Jung Seo

Inje University Ilsan Paik Hospital

maoliang8874@gmail.com+82-31-910-7200

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026